Infertility Treatment

Global Infertility Treatment Market to Reach US$2.8 Billion by 2030

The global market for Infertility Treatment estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Media & Consumables segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.8 Million While China is Forecast to Grow at 9.0% CAGR

The Infertility Treatment market in the U.S. is estimated at US$410.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$647.8 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Infertility Treatment Market - Key Trends & Drivers Summarized

Infertility treatment encompasses a diverse array of medical interventions designed to assist individuals and couples facing challenges in conceiving naturally. These treatments range from pharmacological approaches, such as medications to stimulate ovulation, to surgical procedures addressing anatomical abnormalities in the reproductive system. Assisted reproductive technologies (ART), including in vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI), are at the forefront of infertility treatment, offering advanced solutions for complex infertility issues. Infertility can stem from various causes affecting either or both partners, such as hormonal imbalances, genetic disorders, structural issues in the reproductive organs, and lifestyle factors like stress and diet. The process of undergoing infertility treatment often involves comprehensive testing to diagnose the underlying issues, followed by a tailored treatment plan and continuous monitoring to maximize the chances of a successful pregnancy. Additionally, emotional and psychological support is a crucial component, as the journey can be emotionally taxing and stressful for those involved.

Recent trends in infertility treatment highlight significant advancements in medical technology and increased accessibility to treatment options. Innovations in ART have markedly improved success rates, with notable developments in genetic screening, embryo culture techniques, and cryopreservation. Preimplantation genetic testing (PGT) allows for the selection of embryos free from genetic disorders, enhancing the likelihood of successful implantation and healthy pregnancies. Advances in cryopreservation have improved the viability of frozen eggs, sperm, and embryos, allowing for greater flexibility in family planning. Minimally invasive surgical techniques, such as laparoscopy and hysteroscopy, have also enhanced treatment outcomes by reducing recovery times and minimizing surgical risks. There is a growing trend towards holistic and integrative approaches in infertility treatment, incorporating complementary therapies such as acupuncture, nutrition counseling, and stress management programs. These holistic strategies aim to improve overall reproductive health and support the effectiveness of medical treatments. Additionally, the increasing availability of fertility preservation options, including egg and sperm freezing, reflects societal shifts toward later childbearing due to personal, professional, or medical reasons.

The growth in the infertility treatment market is driven by several factors. Technological advancements, particularly in ART and genetic testing, have significantly enhanced treatment efficacy and success rates, making these options more attractive and accessible to a wider audience. The increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and rising incidences of health issues like obesity, diabetes, and polycystic ovary syndrome (PCOS), has led to a higher demand for infertility treatments. Social and cultural shifts have also played a pivotal role; greater acceptance and awareness of infertility issues have reduced stigma and encouraged more individuals and couples to seek medical help. Legislative changes and the expansion of healthcare coverage and insurance for infertility treatments in various regions have made these services more financially accessible. Furthermore, the rise in disposable income globally, particularly in emerging markets, has led to the growth of fertility clinics and increased availability of advanced infertility treatments. These factors collectively contribute to the dynamic expansion of the infertility treatment market, fostering continuous innovation and making these services more widely available and effective.

SCOPE OF STUDY:

The report analyzes the Infertility Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Equipment, Media & Consumables, Accessories); Procedure (Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgery, Other Procedures); End-Use (Fertility Centers, Hospitals & Surgical Clinics, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 67 Featured) -

• FUJIFILM Holdings Corporation
• Cook Group, Inc.
• EMD Serono, Inc.
• Ferring International Center SA
• Fertipro NV
• FUJIFILM Irvine Scientific
• Esco Micro Pte., Ltd.
• Gynotec B.V.
• Fertility Focus Ltd
• Genea Limited
• European Sperm Bank ApS
• INVO Bioscience
• Hi-Tech Solutions
• Gema sro
• Assisted Reproductive Technology Information System

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.